Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
1.30
- 0.01 (-0.76%)
4:00 PM ET on Aug 23, 2017
Delayed at least 20 minutes.
Day High 1.37
Day Low 1.28
52-Week High 27.36
Volume 148,107
Print Friendly